Aldeyra Therapeutics, Inc.ALDXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-43.21M
↓ 31% below average
Average (9y)
$-32.92M
Historical baseline
Range
High:$-9.40M
Low:$-56.65M
CAGR
+18.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-43.21M | -42.5% |
| 2023 | $-30.33M | +46.5% |
| 2022 | $-56.65M | -33.1% |
| 2021 | $-42.56M | -13.5% |
| 2020 | $-37.49M | +16.7% |
| 2019 | $-44.99M | -49.4% |
| 2018 | $-30.12M | -56.5% |
| 2017 | $-19.25M | -27.0% |
| 2016 | $-15.16M | -61.3% |
| 2015 | $-9.40M | - |